Pharmacogenetics of Therapy in Inflammatory Bowel Disease Patients

Publisher： Bentham Science Publishers

E-ISSN： 1875-6204|5|3|235-247

ISSN： 1570-1603

Source： Current Pharmacogenomics, Vol.5, Iss.3, 2007-09, pp. : 235-247

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacogenetics and Inflammatory Bowel Disease

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 6, Iss. 3, 2008-09 ,pp. : 201-224

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetics of Thiopurines in Inflammatory Bowel Disease

By  

Current Pharmaceutical Design, Vol. 16, Iss. 2, 2010-01 ,pp. : 145-154

Bentham Science Publishers

Access to resources Recommend Favorite

Thiopurines for Inflammatory Bowel Disease: Role of Pharmacogenetics

By  

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 35, Iss. 3, 2005-09 ,pp. : 213-215

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic Drug Monitoring in Patients with Inflammatory Bowel Disease and Established Azathioprine Therapy

By L.P.L. Gilissen  

Clinical Drug Investigation, Vol. 24, Iss. 8, 2004-01 ,pp. : 479-486

Adis International

Access to resources Recommend Favorite

Biologic Therapy for Inflammatory Bowel Disease

By Ardizzone Sandro   Gabriele Bianchi Porro  

Drugs, Vol. 65, Iss. 16, 2005-01 ,pp. : 2253-2286

Adis International

Access to resources Recommend Favorite